Sichuan Huiyu Pharmaceutical Co Ltd (688553) - Total Liabilities

Latest as of September 2025: CN¥1.16 Billion CNY ≈ $169.05 Million USD

Based on the latest financial reports, Sichuan Huiyu Pharmaceutical Co Ltd (688553) has total liabilities worth CN¥1.16 Billion CNY (≈ $169.05 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 688553 net asset momentum to track the company's year-over-year net asset growth rate.

Sichuan Huiyu Pharmaceutical Co Ltd - Total Liabilities Trend (2017–2024)

This chart illustrates how Sichuan Huiyu Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 688553 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Sichuan Huiyu Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Sichuan Huiyu Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Oneness Biotech Co Ltd TWO:4743	Taiwan	NT$872.39 Million
Ironwood Pharmaceuticals Inc NASDAQ:IRWD	USA	$651.71 Million
Yext Inc NYSE:YEXT	USA	$473.64 Million
Pet Acquisition LLC NASDAQ:WOOF	USA	$3.93 Billion
China Television Media Ltd SHG:600088	China	CN¥285.41 Million
Basilea Pharmaceutica AG SW:BSLN	Switzerland	CHF154.06 Million
Mengtian Home Group Inc. SHG:603216	China	CN¥388.60 Million
Mobilicom Limited Warrants NASDAQ:MOBBW	USA	$11.91 Million

Liability Composition Analysis (2017–2024)

This chart breaks down Sichuan Huiyu Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Sichuan Huiyu Pharmaceutical Co Ltd worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.85	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.31	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.24	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sichuan Huiyu Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sichuan Huiyu Pharmaceutical Co Ltd (2017–2024)

The table below shows the annual total liabilities of Sichuan Huiyu Pharmaceutical Co Ltd from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥1.19 Billion ≈ $174.46 Million	+30.84%
2023-12-31	CN¥911.22 Million ≈ $133.34 Million	+63.17%
2022-12-31	CN¥558.44 Million ≈ $81.72 Million	-2.20%
2021-12-31	CN¥571.01 Million ≈ $83.56 Million	+23.79%
2020-12-31	CN¥461.26 Million ≈ $67.50 Million	+2.20%
2019-12-31	CN¥451.33 Million ≈ $66.04 Million	-7.89%
2018-12-31	CN¥490.02 Million ≈ $71.71 Million	+16.14%
2017-12-31	CN¥421.94 Million ≈ $61.74 Million	--

About Sichuan Huiyu Pharmaceutical Co Ltd

SHG:688553 China Drug Manufacturers - Specialty & Generic

Market Cap

$686.19 Million

CN¥4.69 Billion CNY

Market Cap Rank

#10647 Global

#2876 in China

Share Price

CN¥11.07

Change (1 day)

+0.36%

52-Week Range

CN¥9.86 - CN¥27.61

All Time High

CN¥38.07